Prediction of Appropriate Implantable Cardioverter-Defibrillator Therapy Using Machine Learning and Routinely Available Clinical Data

Clicks: 1
ID: 318913
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #43 of 55 articles by views in European Heart Journal - Digital Health

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background and Aims Risk stratification for appropriate implantable cardioverter-defibrillator (ICD) therapy remains imprecise when based on conventional clinical variables alone. We aimed to develop and geographically validate a machine-learning model that integrates routinely available clinical, electrocardiogram, and device interrogation/programming parameters, and quantify the incremental value of non-sustained ventricular tachycardia (NSVT). Methods We retrospectively analysed 514 ICD recipients implanted between 2020 and 2025 at two hospital sites (development cohort) and an independent cohort of 220 patients from a third site (external validation). The endpoint was appropriate ICD therapy (anti-tachycardia pacing or shock). Models were trained using nested stratified cross-validation in the development cohort, and the final refitted model was applied to the external cohort without recalibration. Results In the development cohort, 77/514 patients (15%) experienced appropriate ICD therapy (follow-up 404 days). A base model (Histogram-based gradient boosting) excluding NSVT achieved modest discrimination (ROC-AUC 0.624; average precision 0.198). Adding NSVT improved performance (ROC-AUC 0.805; average precision 0.432). Logistic regression with NSVT achieved comparable discrimination (ROC-AUC 0.78; average precision 0.43), indicating a largely NSVT-driven gain. External validation (event rate 51/220, 23%) confirmed good discrimination (ROC-AUC 0.815; average precision 0.583) with acceptable calibration (Brier score 0.137). At prespecified threshold 0.16 in external validation, sensitivity was 0.78 and specificity 0.74. Conclusion A machine-learning model integrating routinely available clinical, electrocardiogram, and ICD programming/interrogation data may enable prediction of appropriate ICD therapy with preserved performance on geographic external validation. NSVT was the dominant contributor to predictive performance across modelling approaches.
Reference Key
openalex_W7166084944 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Toshinori Chiba, S Wegner, Emanuel Heil, Verena Tscholl, Robert Hättasch, Patrick Nagel, Johannes Lucas, Nikolaos Dagres, Felix Balzer, Alexander Meyer, Wilhelm Haverkamp, F Blaschke, Gerhard Hindricks, Felix Hohendanner
Journal European Heart Journal - Digital Health
Year 2026
DOI
10.1093/ehjdh/ztag102
URL
https://doi.org/10.1093/ehjdh/ztag102
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.